Gadoxetate Injectable Solution 0.25 mmol/mL Suppliers & Bulk Manufacturers
Available Forms: Injectable Solution
Available Strengths: 0.25 mmol/mL
Reference Brands: Eovist(US)
Category: Contrast Agent
Gadoxetate is a gadolinium-based contrast agent that accumulates in liver cells, enhancing MRI images for detailed hepatobiliary assessment. It improves detection of liver lesions, supports early diagnosis, and aids in differentiating benign from malignant tumors. Benefits include high-resolution imaging, early detection, and accurate disease staging.
Product Description: Gadoxetate, marketed as Primovist in the EU and Eovist in the US, is approved for liver MRI by the EMA and FDA for hepatobiliary imaging. Regulatory approval requires a detailed dossier, including clinical efficacy, safety profiles, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical trial and quality data for timely approval, while the EMA ensures regional safety and manufacturing compliance. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence supports swift approval, safe administration, and worldwide availability, supporting early diagnosis and optimal management of liver diseases across healthcare regions globally.
Gadoxetate Injectable Solution — third party manufacturing & bulk supply
Gadoxetate Injectable Solution 0.25 mmol/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Gadoxetate Injectable Solution is supplied as Injectable Solution — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Gadoxetate Injectable Solution listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Gadoxetate Injectable Solution →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Gadobenate Dimeglumine
Strength:
529 mg/mL
Form: Injection
Reference Brands: MultiHance (USA)
View Details
Gadopiclenol
Strength:
0.25 mmol/mL
Form: Injection
Reference Brands: Elucirem (USA), Vueway(EU)
View Details
Perflutren
Strength:
0.19 mg/ ml
Form: Injection
Reference Brands: Definity (USA), Optison (USA), Luminity (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
